HOME
 CONTACT
 
 
CORPORATE PRODUCTS & TECHNOLOGY PATIENTS CLINICAL TRIAL NEWS JOBS
 
News Articles Events Publications
 

For Release: 7:00 am EST on October 15, 2007

Facet Solution’s ACADIA™ implant demonstrates positive clinical results after one year follow up

LOGAN, UTAH (October 15, 2007) – Facet Solutions, Inc. announced today that it has completed one year follow-up on the first cohort of patients to receive its ACADIA™ Facet Replacement System (ACADIA™). The clinical outcomes for these patients at one year include a significant decline in leg and back pain; improved motion and function; and no post-operative complications. Additionally, the first patient in the ACADIA™ study has completed the two year follow up evaluation with similarly positive results.

The ACADIA™ has been developed by Facet Solutions, Inc. to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to lumbar spinal fusion. The ACADIA™ procedure includes replacing the diseased facet joint with an anatomic implant that restores the natural motion, stability, and balance to the lumbar spine.

An international team of Orthopedic surgeons began the initial ACADIA™ study at the Hospital Servidor Publico Estadol in São Paulo in late September 2005. The team included Dr. Allen Carl of Albany Medical Center in Albany, New York and Dr. Carlos Oliveira of São Paulo, Brazil.

“I believe that the early clinical results for the ACADIA™ clearly demonstrate that this new Treatment option is improving the quality of life for my patients who would otherwise lose significant motion using current fusion or dynamic stabilization devices,” Dr. Oliviera stated. "In fact, many of my patients were having fusions and would come back four and five years later needing a subsequent fusion at adjacent levels as a result of the reduction in motion at the original fused level of the spine. I anticipate that this technology will ultimately become the surgical standard of care for spinal stenosis patients in the future.”

“Facet Solutions is very pleased with the early clinical experience”, added Eric Bannon, VP of Clinical Affairs. “The company looks forward to expanding this clinical outcome data with results from an ongoing FDA approved IDE Study which was recently expanded to eight sites within the United States.”

The summary findings from this evaluation will be presented a the Science of Facet Joint Repair and Total Posterior Arthroplasty Symposium which will be held in Austin, Texas at the Omni Hotel on Monday, October 22, 2007 at 6:30 PM.

*Note: ACADIA™ is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture backed company that is focused on developing and commercializing surgical devices for the Treatment of facet related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is FDA registered and is certified to ISO 13485.

# # #


Press Contact

Eric Olson
VP of Sales and Marketing
Facet Solutions, Inc.
435.753.1671 x-121
eolson@facetsolutions.com


 

Facet Solutions, Inc . • 45 South Street • Hopkinton, MA 01748 • phone: 508-435-2492 fax: 508-435-4503
© 2006 Facet Solutions, Inc. All Rights Reserved 1024 Rev. B